Tscan Therapeutics Inc. (TCRX) NASDAQ
$7.73 (0.07) (-0.90%)
Market Cap: $340.30M
As of 05/10/24 04:00 PM EDT. Market closed.
Tscan Therapeutics Inc. (TCRX)
NASDAQ
$7.73
(0.07) (-0.90%)
Market Cap: $340.30M
As of 05/10/24 04:00 PM EDT. Market closed.
Add to Portfolio
harnessing novel t cell systems to extend the promise of ... read more
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Full Time Employees
127
URL
Address
.
PRICE CHART FOR TSCAN THERAPEUTICS INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$8.09
Previous Close
$7.80
Days Range
$7.67 - $8.22
52 week range
$1.93 - $9.09
Volume
114,185
Avg. Volume (30 days)
237,741
Market Cap
$340.30M
Dividend Yield
-
P/E
(3.81)
Shares Outstanding
43,628,149
Open
$8.09
Previous Close
$7.80
Days Range
$7.67 - $8.22
52 week range
$1.93 - $9.09
Volume
114,185
Avg. Volume (30 days)
237,741
Market Cap
$340.30M
Dividend Yield
-
P/E
(3.81)
Shares Outstanding
43,628,149
FINANCIAL STATEMENTS FOR TSCAN THERAPEUTICS INC
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR TSCAN THERAPEUTICS INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| BARBERICH TIMOTHY J | Director | Dec 19, 2023 | Buy | $4.97 | 317 | 1,575 | 67,027 | Dec 21, 2023, 05:00 PM |
| BARBERICH TIMOTHY J | Director | Dec 18, 2023 | Buy | $4.89 | 28,830 | 140,881 | 66,710 | Dec 21, 2023, 05:00 PM |
| Klencke Barbara | Director | Dec 14, 2023 | Buy | $5.08 | 5,000 | 25,400 | 30,000 | Dec 18, 2023, 06:01 PM |
| BARBERICH TIMOTHY J | Director | Jun 02, 2023 | Buy | $2.63 | 37,880 | 99,564 | 37,880 | Jun 06, 2023, 07:53 PM |
| Lynx1 Capital Management LP | 10% Owner | May 31, 2023 | Sale | $2.52 | 25,400 | 63,953 | 5,240,000 | Jun 02, 2023, 05:35 PM |
| Silver Brian M. | Chief Financial Officer | Dec 28, 2022 | Buy | $1.56 | 3,158 | 4,941 | 32,885 | Dec 29, 2022, 02:34 PM |
| Silver Brian M. | Chief Financial Officer | Dec 27, 2022 | Buy | $1.50 | 2,842 | 4,276 | 29,727 | Dec 29, 2022, 02:34 PM |
| SOUTHWELL DAVID P | Chief Executive Officer | May 18, 2022 | Buy | $3.59 | 25,000 | 89,821 | 171,569 | May 20, 2022, 04:15 PM |
| BAKER BROS. ADVISORS LP | Director | May 11, 2022 | Buy | $1.99 | 25,865 | 51,350 | 2,528,583 | May 12, 2022, 04:41 PM |
| BAKER BROS. ADVISORS LP | Director | May 10, 2022 | Buy | $1.88 | 1,333,927 | 2,507,804 | 2,505,600 | May 12, 2022, 04:41 PM |
| Silver Brian M. | Chief Financial Officer | Mar 24, 2022 | Buy | $3.40 | 15,000 | 50,982 | 26,885 | Mar 28, 2022, 04:31 PM |
| SOUTHWELL DAVID P | Chief Executive Officer | Dec 23, 2021 | Option Exercise | $1.97 | 48,670 | 95,880 | 146,569 | Dec 27, 2021, 04:30 PM |
| ZDRAVESKI ZORAN | Chief Legal Officer | Sep 23, 2021 | Buy | $7.48 | 4,716 | 35,255 | 4,716 | Sep 27, 2021, 05:22 PM |
| Silver Brian M. | Chief Financial Officer | Sep 21, 2021 | Buy | $6.32 | 5,000 | 31,585 | 11,885 | Sep 22, 2021, 06:51 PM |
| MacBeath Gavin | Chief Scientific Officer | Sep 21, 2021 | Buy | $6.19 | 57 | 353 | 49,767 | Sep 22, 2021, 06:48 PM |
| MacBeath Gavin | Chief Scientific Officer | Sep 20, 2021 | Buy | $6.22 | 4,943 | 30,744 | 49,710 | Sep 22, 2021, 06:48 PM |
| Silver Brian M. | Chief Financial Officer | Sep 09, 2021 | Buy | $8.48 | 5,885 | 49,925 | 6,885 | Sep 13, 2021, 04:37 PM |
| SOUTHWELL DAVID P | Chief Executive Officer | Sep 08, 2021 | Buy | $8.73 | 11,000 | 96,066 | 97,899 | Sep 09, 2021, 04:43 PM |
| Desmarais William | Chief Business Officer | Aug 27, 2021 | Buy | $9.08 | 2,500 | 22,708 | 2,500 | Aug 31, 2021, 05:56 PM |
| Westphal Christoph H | 10% Owner | Jul 20, 2021 | Buy | $15.00 | 133,333 | 1,999,995 | 1,278,838 | Jul 22, 2021, 04:46 PM |
| BAKER BROS. ADVISORS LP | Director | Jul 20, 2021 | Buy | $15.00 | 1,425,000 | 21,375,000 | 1,320,302 | Jul 22, 2021, 04:06 PM |
| Silver Brian M. | Chief Financial Officer | Jul 20, 2021 | Buy | $15.00 | 1,000 | 15,000 | 1,000 | Jul 22, 2021, 07:37 AM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| BARBERICH TIMOTHY J | Director | 12/19/2023 | 1,575 |
| BARBERICH TIMOTHY J | Director | 12/18/2023 | 140,881 |
| Klencke Barbara | Director | 12/14/2023 | 25,400 |
| BARBERICH TIMOTHY J | Director | 06/02/2023 | 99,564 |
| Lynx1 Capital Management LP | 10% Owner | 05/31/2023 | 63,953 |
| Silver Brian M. | Chief Financial Officer | 12/28/2022 | 4,941 |
| Silver Brian M. | Chief Financial Officer | 12/27/2022 | 4,276 |
| SOUTHWELL DAVID P | Chief Executive Officer | 05/18/2022 | 89,821 |
| BAKER BROS. ADVISORS LP | Director | 05/11/2022 | 51,350 |
| BAKER BROS. ADVISORS LP | Director | 05/10/2022 | 2,507,804 |
| Silver Brian M. | Chief Financial Officer | 03/24/2022 | 50,982 |
| SOUTHWELL DAVID P | Chief Executive Officer | 12/23/2021 | 95,880 |
| ZDRAVESKI ZORAN | Chief Legal Officer | 09/23/2021 | 35,255 |
| Silver Brian M. | Chief Financial Officer | 09/21/2021 | 31,585 |
| MacBeath Gavin | Chief Scientific Officer | 09/21/2021 | 353 |
| MacBeath Gavin | Chief Scientific Officer | 09/20/2021 | 30,744 |
| Silver Brian M. | Chief Financial Officer | 09/09/2021 | 49,925 |
| SOUTHWELL DAVID P | Chief Executive Officer | 09/08/2021 | 96,066 |
| Desmarais William | Chief Business Officer | 08/27/2021 | 22,708 |
| Westphal Christoph H | 10% Owner | 07/20/2021 | 1,999,995 |
| BAKER BROS. ADVISORS LP | Director | 07/20/2021 | 21,375,000 |
| Silver Brian M. | Chief Financial Officer | 07/20/2021 | 15,000 |
Load More Insider Transactions
FUNDS WITH A POSITION IN TSCAN THERAPEUTICS INC
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 3,900,000 | 0.05% | -2.5% | Other |
| BAKER BROS. ADVISORS LP | 2,828,938 | 0.21% | 1.59% | Other |
| BLACKROCK INC. | 1,699,213 | 0.00031% | 1.64% | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 391,646 | 0.00024% | 27.18% | Other |
| BALYASNY ASSET MANAGEMENT L.P. | 45,986 | 0.0005% | New | Event Driven |
| RENAISSANCE TECHNOLOGIES LLC | 21,700 | 0.0002% | 22.6% | Other |
BUYBACK ANNOUNCEMENT(S) FOR TSCAN THERAPEUTICS INC
LOADING...